Promoting Recovery After STroke With Amantadine (NCT05140148)
🩺 Plain-English Summary (8th-Grade Level)
The investigators aim to examine whether amantadine can help patients recover from stroke. This will be a blinded randomized clinical trial (RCT). Patients will be randomized post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine arm. Patients will be on study drug or placebo for 1 month but will be enrolled for 3 months total. At various time points patients will be examined and fill out questionnaires to determine level of stroke recovery.
Who can join: Review the eligibility criteria below.
Location: The Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (267) 624-4442
Email: aaron.rothstein@pennmedicine.upenn.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Stroke, Ischemic
- Determinants of the Effectiveness of Robot-assisted Hand Movement Training — Irvine, California
- Visual Rehabilitation After Occipital Stroke — Rochester, New York
- Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke — London, Ontario
- The REACTplusNMES Trial: A Double-blinded RCT — Chicago, Illinois
- Transitional Care Program to Improve Risk Factors in Stroke Survivors — Winchester, Virginia
- DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients) — Atlanta, Georgia
Explore by condition: All Stroke, Ischemic clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.